MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer

Abstract

Some colorectal cancers arise from a field defect defined by epigenetic inactivation of MGMT. Detection of this abnormality may ultimately be useful in risk assessment for colorectal cancer.